APA (7th ed.) Citation

A, M., AM, R., A, B., & L, M. (2022). Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: Suspected adverse events reporting is the milestone of post-marketing surveillance. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 43(7), 4095. https://doi.org/10.1007/s10072-022-05961-9

Chicago Style (17th ed.) Citation

A, Mariottini, Repice AM, Barilaro A, and Massacesi L. "Anti-SARS-Cov2 Vaccination at the Time of the COVID-19 Pandemic: Suspected Adverse Events Reporting Is the Milestone of Post-marketing Surveillance." Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 43, no. 7 (2022): 4095. https://doi.org/10.1007/s10072-022-05961-9.

MLA (9th ed.) Citation

A, Mariottini, et al. "Anti-SARS-Cov2 Vaccination at the Time of the COVID-19 Pandemic: Suspected Adverse Events Reporting Is the Milestone of Post-marketing Surveillance." Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, vol. 43, no. 7, 2022, p. 4095, https://doi.org/10.1007/s10072-022-05961-9.